L&C BIO Co.,LTD (KOSDAQ:290650)
69,700
+5,800 (9.08%)
Apr 10, 2026, 3:30 PM KST
L&C BIO Co.,LTD Revenue
In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B KRW with 18.66% growth. L&C BIO Co.,LTD had revenue of 24.67B in the quarter ending December 31, 2025, with 29.00% growth.
Revenue
85.48B
Revenue Growth
+18.66%
P/S Ratio
18.58
Revenue / Employee
606.22M
Employees
141
Market Cap
1.59T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 85.48B | 13.44B | 18.66% |
| Dec 31, 2024 | 72.03B | 6.11B | 9.26% |
| Dec 31, 2023 | 65.93B | 13.35B | 25.40% |
| Dec 31, 2022 | 52.57B | 6.90B | 15.10% |
| Dec 31, 2021 | 45.68B | 12.70B | 38.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Seegene | 474.23B |
| i-SENS | 315.44B |
| InBody Co.,Ltd | 233.95B |
| WON TECH | 156.84B |
| Osang Healthcare Co.,Ltd | 128.63B |
| DRTECH | 116.30B |
| Bio Plus | 90.90B |
| Curexo | 74.53B |